Eli Lilly & Co (LLY)

$788.77 0.32 (0.04%)

20:00 EDT LLY Stock Quote Delayed 30 Minutes

Mid-Year Momentum Plays: 7 Stocks to Buy for the Second Half

By Josh Enomoto, InvestorPlace Contributor Jun 6, 2024

There’s certainly some level of comfort in bidding up the same names as everybody else. But the most satisfying returns stem from momentum stocks that…

Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential

Institutional Bets: 7 Stocks the Big Money Will Send Higher This Year

Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit

Volume:

Previous Close $818.22

Market Cap 775.81B

PE Ratio 67.34

EPS 11.7139

Volume (Avg. Vol.) 2.67M

Day's Range $787.06 - $818.79

52-Week Range $710.07 - $969.31

Dividend & Yield $5.40 (0.68%)

LLY Stock Predictions, Articles, and Eli Lilly & Co News

3 Sorry Pharma Stocks to Sell in May While You Still Can

By Matthew Farley, InvestorPlace Contributor May 29, 2024

Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.

The Dividend Acceleration Squad: 3 Stocks With Rapidly Rising Yields

By Alex Sirois, InvestorPlace Contributor May 28, 2024

Dividend stocks that grow their returns faster than others are worth considering for investors interested in growing their incomes.

7 Stocks to Buy if the Market Ends Up Plunging

By Josh Enomoto, InvestorPlace Contributor May 24, 2024

Stocks to buy if the market fails: that’s the other side of the coin to the search query, is the market overvalued right now? Pop…

3 Biotech Stocks to Buy on the Dip: May 2024

By Joel Lim, InvestorPlace Contributor May 23, 2024

These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.

The 500 Top Stocks to Buy in May, According to AI

By Thomas Yeung, CFA, InvestorPlace Markets Analyst May 22, 2024

MarketMaster AI tells us that the top stocks to buy in May represent high-quality companies with strong fundamentals.

Retire Rich: 3 Game-Changing Stocks to Own for the Next 10 Years

By Chris MacDonald, InvestorPlace Contributor May 22, 2024

Here are three game-changing retirement stocks to own for the long-term, for those looking to create meaningful long-term wealth.

3 S&P 500 Stocks to Buy in May Before They Rocket Higher

By Chris MacDonald, InvestorPlace Contributor May 21, 2024

These three stocks sit on the precipice of huge, long-term gains, making them among the best to grab now before they soar.

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?

By Alex Sirois, InvestorPlace Contributor May 17, 2024

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

Rally Rockets: 3 Stocks Benefitting From the Market’s Unstoppable Surge

By Tezcan Gecgil, InvestorPlace Contributor May 17, 2024

Don't miss out on profit potential of these stocks to buy. Explore three top stocks poised to unlock gains in a surging market.

The Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024

By Faizan Farooque, InvestorPlace Contributor May 16, 2024

Amid economic shifts, pinpoint dividend stocks to buy: Disney's recovery, Walmart's expansion, and Eli Lilly's medical innovations stand out.

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

By Alex Sirois, InvestorPlace Contributor May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

Wall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024

By Joel Baglole, InvestorPlace Contributor May 15, 2024

Many growth stocks are benefiting from sector-specific catalysts whether it be demand for artificial intelligence products, a rebound in online advertisements, or the continued strength of consumer spending.

Biotech Behemoths: 3 Giants Set to Dominate the Health Scene

By Joey Frenette, InvestorPlace Contributor May 14, 2024

The biotech behemoths stand out as compelling and exciting options for investors seeking steady long-term growth.

The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory

By Rich Duprey, InvestorPlace Contributor May 13, 2024

These three companies could soon be the next bargain stocks to buy as the market adjusts to their developing situations.

Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season

By Joey Frenette, InvestorPlace Contributor May 10, 2024

It's been a rather eventful earnings season that was make or break for many high-flyers. Here are three earnings-resilient tech stocks.

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

By Josh Enomoto, InvestorPlace Contributor May 7, 2024

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because…

3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now

By Rick Orford, InvestorPlace Contributor May 2, 2024

These three stocks closing in on trillion-dollar valuations are ready to stand shoulder-to-shoulder with other industry giants.

Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)

By Joel Baglole, InvestorPlace Contributor May 1, 2024

Investors should take note of this earnings season winners and losers to see how stocks they own are doing now Q1 results have been released.

Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge

By Viktor Zarev, InvestorPlace Contributor May 1, 2024

A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.

3 Pharma Stocks With the Potential to Make You an Overnight Millionaire

By Chandler Capital, InvestorPlace Contributor May 1, 2024

As a result of their enduring significance in healthcare, the pharma industry offers both short and long term opportunities in pharma stocks.

Eli Lilly & Co (LLY)

Mid-Year Momentum Plays: 7 Stocks to Buy for the Second Half

Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential

Institutional Bets: 7 Stocks the Big Money Will Send Higher This Year

Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly & Co (LLY)

LLY Stock Predictions, Articles, and Eli Lilly & Co News

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Subscriber Sign in